RSC Advances,
Journal Year:
2024,
Volume and Issue:
14(45), P. 32818 - 32826
Published: Jan. 1, 2024
The
alarming
escalation
in
cancer
incidence
and
mortality
has
thrust
into
spotlight
the
quest
for
groundbreaking
therapeutic
strategies.
Our
research
delves
potential
of
RDIR780,
a
novel
class
biomimetic
nanoparticles
cloaked
red
blood
cell
membranes,
to
significantly
enhance
their
Chemical Society Reviews,
Journal Year:
2023,
Volume and Issue:
52(13), P. 4392 - 4442
Published: Jan. 1, 2023
Metal
agents
have
made
incredible
strides
in
preclinical
research
and
clinical
applications,
but
their
short
emission/absorption
wavelengths
continue
to
be
a
barrier
distribution,
therapeutic
action,
visual
tracking,
efficacy
evaluation.
Chemical Society Reviews,
Journal Year:
2024,
Volume and Issue:
53(6), P. 3167 - 3204
Published: Jan. 1, 2024
We
report
strategies
employed
by
metallacycle/metallacage-based
supramolecular
coordination
complexes
to
enhance
water
solubility
and
biostability
reduce
potential
toxicity
side
effects
for
biomedical
applications.
Advanced Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 10, 2025
Abstract
Photodynamic
therapy
(PDT)
and
photothermal
(PTT)
have
emerged
as
promising
treatment
options,
showcasing
immense
potential
in
addressing
both
oncologic
nononcologic
diseases.
Single‐component
organic
phototherapeutic
agents
(SCOPAs)
offer
advantages
compared
to
inorganic
or
multicomponent
nanomedicine,
including
better
biosafety,
lower
toxicity,
simpler
synthesis,
enhanced
reproducibility.
Nonetheless,
how
further
improve
the
therapeutic
effectiveness
of
SCOPAs
remains
a
challenging
research
area.
This
review
delves
deeply
into
strategies
performance
PDT
PTT
by
optimizing
structural
design
SCOPAs.
These
encompass
augmenting
reactive
oxygen
species
(ROS)
generation,
mitigating
dependence,
elevating
light
absorption
capacity,
broadening
region,
enhancing
conversion
efficiency
(PCE).
Additionally,
this
also
underscores
ideal
for
developing
with
balanced
PTT.
Furthermore,
synergies
are
highlighted
between
other
modalities
such
ferroptosis,
gas
therapy,
chemotherapy,
immunotherapy.
By
providing
comprehensive
analysis
these
strategies,
aspires
serve
valuable
resource
clinicians
researchers,
facilitating
wider
application
advancement
SCOPAs‐mediated
Nano-Micro Letters,
Journal Year:
2023,
Volume and Issue:
16(1)
Published: Nov. 20, 2023
Massive
efforts
have
been
concentrated
on
the
advance
of
eminent
near-infrared
(NIR)
photothermal
materials
(PTMs)
in
NIR-II
window
(1000-1700
nm),
especially
organic
PTMs
because
their
intrinsic
biological
safety
compared
with
inorganic
PTMs.
However,
so
far,
only
a
few
NIR-II-responsive
was
explored,
and
conversion
efficiencies
(PCEs)
still
remain
relatively
low.
Herein,
donor-acceptor
conjugated
diradical
polymers
open-shell
characteristics
are
explored
for
synergistically
immunotherapy
metastatic
tumors
window.
By
employing
side-chain
regulation,
polymer
TTB-2
obvious
absorption
developed,
its
nanoparticles
realize
record-breaking
PCE
87.7%
upon
light
illustration.
In
vitro
vivo
experiments
demonstrate
that
show
good
tumor
photoablation
navigation
photoacoustic
imaging
window,
without
any
side-effect.
Moreover,
by
combining
PD-1
antibody,
pulmonary
metastasis
breast
cancer
is
high-effectively
prevented
efficient
photo-immunity
effect.
Thus,
this
study
explores
superior
theranostics
offering
new
horizon
developing
radical-characteristic
materials.
ACS Applied Materials & Interfaces,
Journal Year:
2024,
Volume and Issue:
16(27), P. 34607 - 34619
Published: June 26, 2024
Photothermal
therapy
(PTT),
which
uses
the
high
thermal
conversion
ability
of
photothermal
agents
to
ablate
tumor
cells
at
temperatures,
has
gained
significant
attention
because
it
advantages
selectivity
and
specificity,
precise
targeting
sites,
low
invasiveness
trauma.
However,
PTT
guided
by
NIR-I
limitations
in
tissue
penetration
depth,
resulting
limited
imaging
monitoring
therapeutic
effects
on
deep-seated
tissues.
Moreover,
nanoparticles
are
easily
cleared
immune
system
difficult
passively
target
sites
during
process
treatment.
To
address
these
issues,
we
prepared
using
NIR-II
dyes
IR1048
DSPE-PEG-OH
further
encapsulated
them
red
blood
cell
membranes
derived
from
mice.
These
biomimetic
nanoparticles,
called
RDIR1048,
showed
reduced
clearance
had
long
circulation
characteristics.
They
effectively
accumulated
strong
fluorescence
could
still
be
observed
site
96
h
after
administration.
Furthermore,
through
mouse
experiments,
found
that
RDIR1048
exhibited
good
ability.
When
used
combination
with
an
checkpoint
inhibitor,
anti-PD-L1
antibodies,
enhanced
immunogenic
death
caused
improved
effect
immunotherapy,
demonstrated
efficacy
treatment
tumor-bearing
This
study
provides
a
feasible
basis
for
future
development
properties.